ImmunityBio, Inc. IBRX

Makary is out friend hang in there FDA has been corrupted by big Pharma $$$$ for years every Trump appointment is cleaning up the 3 letters takes some time.

IBRX should have a chart like that

Wow you would think they cured a cancer or have at least 2 FDAs and the only treatment for Lymphopenia!

MSM vs being blackballed by them

Chris try AI or good old Google

I like reading how people posting are trying to wake the world up to ImmunityBio

THANKS THANKS THANKS WE NEED MSM TO GET A STOCK PRICE THAR REFLECTS TO POTENTIAL

The negative posters would you just please go away! Why would you post if you think IBRX is a stinker stock! Just get the F off the board!

I have explained the situation about the stock price. Hello it's a full on black balling of ImmunityBio because Big Pharma spends Billions BILLIONS advertising their crappy therapies, no cures on MSM and MSM loves the $$$$$! So we get no MSM coverage! In the end good prevails!

So please go away and F off!!!!

The old FDA only cared about $ and big pharma that's over!

We don't need rocketing sales and profits for IBRX to rocket it would with hyper interest based on the future if thousands, millions more knew about Anktiva and BioShield

AIDS cure will blow up this

"The global HIV drugs market was valued at $34.13 billion in 2023, and is projected to grow to $58.24 billion by 2032."

There maybe some resistance from the big pharma world to stop ImmunityBio!

HIV drugs plus Keytruda 70-100 billion in lost sales!

Anktiva and BioShield could wipe out 100-200 billion in revenues!

If Dr Mackary had said ImmunityBio has a therapy that can eliminate stage 4 cancers

Stock would be $$100 next week

So keep day trading IBRX and I hope you are out the day the news arrives on MSM

I wouldn't sell a single share of my 300,000 risking I was out when the news hits MSM

Short squeeze would happen and we could see $100 plus

Ok Ok I keep trying to beat this into everyone's head. We need MSM using the name Anktiva, BioShield and the name of the company, ImmunityBio. Need an interview on cnbc foxb for the stock to have a meaningful run up!

Until that happens $2-$4 is the range with no widespread media coverage!